Luxembourg Institute of Health (LIH)
|Address||1A-B rue Thomas Edison
|Platforms||ATMP & Biological, Biomarkers, Vaccines|
|Tags||Genomics, Immunity, Infection, Luxembourg, Luxembourg Institute of Health, Oncology, Population Health|
The Luxembourg Institute of Health is a public biomedical research organisation. Striving for excellence, its researchers, by their creativity, enthusiasm and commitment, generate knowledge on disease mechanisms and contribute to the development of new diagnostics, innovative therapies and clinical applications that impact the healthcare of Luxembourgish and European citizens.
At the forefront of biomedical sciences, the Luxembourg Institute of Health is deeply involved in implementing national and international research programs in personalized medicine. It acts as a catalyst for promoting research collaborations with healthcare providers, hospitals and other public and private biomedical organisations. To create economic and societal value, it purposes the translation of its scientific discoveries and technological developments. As the first supplier of public health information in Luxembourg, it also enables public authorities to make decisions based on scientific data and to communicate validated data to international institutions.
Transversal translational Medicine at LIH:
The Transversal Translational Medicine (TTM) group was created at the LIH to enhance the ability of biomedical stakeholder institutions to work translationally. TTM aims to foster bed-to-bench-to-bed collaborations within LIH, inter-institutionally across Luxembourg and internationally, in view of implementing translational programmes across research topics, supported by specific platforms and infrastructures bridging between fundamental research and real-world healthcare
The activities of the Luxembourg Institute of Health are developed within the following research topics, also reflected in its department structure: Oncology, Infection and Immunity, Population Health.
Department of Infection and Immunity (DII) aims to understand the complex mechanisms of infectious and inflammatory disease processes in order to enable new ways to diagnose, prevent or cure human diseases. Such a strategy requires the existence of a highly interdisciplinary research environment with intensive collaboration of basic and clinical immunologists, engineers, biochemists, computational and systems biologists, public health specialists and clinician scientists
Department of Oncology (DONC): Its vision is to execute world-class cancer research within certain prioritised areas based on strong intradepartmental scientific track records, and to provide research expertise covering the most common cancer types that represents a health problem in Luxembourg. The department also represents a state-of-the art training ground for next generation cancer researchers in Luxembourg, -and acts as a reference point for cancer research at the national level
The Department of Population Health (DoPH) is an interdisciplinary research centre focusing on epidemiology and public health research across a wide range of areas including cardio-metabolic conditions, sports medicine, human bio-monitoring, health economics and clinical investigations. By the evidence we generate, we aim at tackling the major causes of morbidity and mortality, improving quality of life and informing clinical and public health guidelines in the country
The Luxembourg Institute of Health hosts a large number of trainees, Master students and PhD candidates, affiliated to the University of Luxembourg or to foreign partner universities, as well as postdoctoral scientists specialising themselves in a given research domain. Modern infrastructure, state-of-the-art technologies and a stimulating work environment, guaranteeing quality supervision and training, are provided to these young scientists starting their career.